NEW YORK (GenomeWeb) – Becton Dickinson today reported a 2 percent year over year increase in fiscal first quarter revenues as growth in both its Life Sciences and Medical segments was tempered by an unfavorable currency impact.

For the three months ended Dec. 31, BD reported revenues of $2.05 billion compared to $2.02 billion in the same quarter last year and beating analysts' consensus estimate of $2.01 billion. On a currency-neutral basis, revenues increased about 5 percent year over year, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.